Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5949567 | Atherosclerosis | 2011 | 5 Pages |
Abstract
Vevostrain can be used to assess the longitudinal CCA movement in mice. In analogy with findings in humans, lower longitudinal CCA movement is associated with greater plaque burden in mice.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Sara Svedlund, Li-ming Gan,